Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianela Candolfi

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Regulatory Peptides|March 1, 2003
Effects of lipopolysaccharide on neurokinin A content and release in the hypothalamic-pituitary axisAndrea De Laurentiis, Marianela Candolfi, Daniel Pisera, et al.
Life Sciences|September 5, 2003
Characterization of tachykinin NK2 receptor in the anterior pituitary glandDaniel Pisera, Marianela Candolfi, Andrea De Laurentiis, et al.
Neuromethods|August 30, 2019
Rodent Glioma Models: Intracranial Stereotactic Allografts and XenograftsHikmat Assi, Marianela Candolfi, Pedro R Lowenstein, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 2014
Polyunsaturated fatty acids and gliomas: a critical review of experimental, clinical, and epidemiologic dataSilvana Silvia Sandrone, Gaston Repossi, Marianela Candolfi, et al.
Neuroendocrinology|October 12, 2004
Tumor necrosis factor-alpha-induced nitric oxide restrains the apoptotic response of anterior pituitary cellsMarianela Candolfi, Gabriela Jaita, Verónica Zaldivar, et al.
Molecular Cancer Therapeutics|March 19, 2008
Turning the gene tap off; implications of regulating gene expression for cancer therapeuticsJames F Curtin, Marianela Candolfi, Weidong Xiong, et al.
Neuroscience Letters|August 22, 2012
Gene therapy for brain tumors: basic developments and clinical implementationHikmat Assi, Marianela Candolfi, Gregory Baker, et al.
Neuroimmunomodulation|September 26, 2002
Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axisAndrea De Laurentiis, Daniel Pisera, Carla Caruso, et al.
Current Gene Therapy|February 7, 2006
Gene therapy and targeted toxins for gliomaGwendalyn D King, James F Curtin, Marianela Candolfi, et al.
Expert Opinion on Therapeutic Targets|September 8, 2020
The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?Antonela S Asad, Alejandro J Nicola Candia, Nazareno Gonzalez, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Regulatory Peptides|March 1, 2003
Effects of lipopolysaccharide on neurokinin A content and release in the hypothalamic-pituitary axisAndrea De Laurentiis, Marianela Candolfi, Daniel Pisera, et al.
Life Sciences|September 5, 2003
Characterization of tachykinin NK2 receptor in the anterior pituitary glandDaniel Pisera, Marianela Candolfi, Andrea De Laurentiis, et al.
Neuromethods|August 30, 2019
Rodent Glioma Models: Intracranial Stereotactic Allografts and XenograftsHikmat Assi, Marianela Candolfi, Pedro R Lowenstein, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 2014
Polyunsaturated fatty acids and gliomas: a critical review of experimental, clinical, and epidemiologic dataSilvana Silvia Sandrone, Gaston Repossi, Marianela Candolfi, et al.
Neuroendocrinology|October 12, 2004
Tumor necrosis factor-alpha-induced nitric oxide restrains the apoptotic response of anterior pituitary cellsMarianela Candolfi, Gabriela Jaita, Verónica Zaldivar, et al.
Molecular Cancer Therapeutics|March 19, 2008
Turning the gene tap off; implications of regulating gene expression for cancer therapeuticsJames F Curtin, Marianela Candolfi, Weidong Xiong, et al.
Neuroscience Letters|August 22, 2012
Gene therapy for brain tumors: basic developments and clinical implementationHikmat Assi, Marianela Candolfi, Gregory Baker, et al.
Neuroimmunomodulation|September 26, 2002
Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axisAndrea De Laurentiis, Daniel Pisera, Carla Caruso, et al.
Current Gene Therapy|February 7, 2006
Gene therapy and targeted toxins for gliomaGwendalyn D King, James F Curtin, Marianela Candolfi, et al.
Expert Opinion on Therapeutic Targets|September 8, 2020
The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?Antonela S Asad, Alejandro J Nicola Candia, Nazareno Gonzalez, et al.
Pageof 9